FDA orphan drug designation: treatment of alpha-1 antitrypsin deficiency
All entries for: Tessera Therapeutics Inc.
November 6, 2025
Tessera Therapeutics Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of alpha-1 antitrypsin deficiency